Published in Drug Week, December 16th, 2005
The Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT), funded by the U.S. National Institutes of Health (NIH), rigorously evaluated the efficacy and safety of glucosamine and chondroitin in 1258 people, concluding in its abstract that the "combination of glucosamine and chondroitin sulfate is effective in treating moderate to severe knee pain due to osteoarthritis."
GAIT lead researcher Daniel O. Clegg, MD, professor of medicine and chief of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week